Review article · 2025
Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications
Expert Opinion on Drug Safety, 1–13 · Published 6 May 2025 · DOI 10.1080/14740338.2025.2502037
In brief
“Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications” is a 2025 review article by Xiaoqi Li and 2 co-authors, published in Expert Opinion on Drug Safety. OpenAlex counts 10 citations as of 19 November 2026, which puts it in the top 7% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 10
- Most cited in
- 2026 (7)
- Field-weighted impact
- 1.04
- References
- 107
- Authors
- 3
Abstract
INTRODUCTION: To compare the risks of serious infections, herpes zoster (HZ), and opportunistic infections associated with Janus kinase (JAK) inhibitors versus placebo, tumor necrosis factor-α inhibitors (TNFi), methotrexate (MTX), and among different JAK inhibitors. METHODS: We searched PubMed, Embase, Cochrane Library, and Web of Science databases from their inception until 23 January 2024. Network meta-analysis… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, X., Hu, Q., & Xu, T. (2025). Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications. Expert Opinion on Drug Safety, 1–13. https://doi.org/10.1080/14740338.2025.2502037
MLA 9
Li, Xiaoqi, et al. “Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications.” Expert Opinion on Drug Safety, 2025, pp. 1–13. https://doi.org/10.1080/14740338.2025.2502037.
Chicago
Li, Xiaoqi, Qiaozhi Hu, and Ting Xu. 2025. “Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications.” Expert Opinion on Drug Safety: 1–13. https://doi.org/10.1080/14740338.2025.2502037.
Harvard
Li, X., Hu, Q. and Xu, T. (2025) ‘Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications’, Expert Opinion on Drug Safety, pp. 1–13. doi:10.1080/14740338.2025.2502037.
IEEE
X. Li, Q. Hu, and T. Xu, “Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications,” Expert Opinion on Drug Safety, pp. 1–13, 2025, doi: 10.1080/14740338.2025.2502037.
BibTeX
@article{li2025janus,
title = {{Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications}},
author = {Li, Xiaoqi and Hu, Qiaozhi and Xu, Ting},
journal = {Expert Opinion on Drug Safety},
year = {2025},
pages = {1--13},
doi = {10.1080/14740338.2025.2502037},
url = {https://doi.org/10.1080/14740338.2025.2502037}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- JAK inhibitors
- serious infections
- herpes zoster
- opportunistic infections
- tofacitinib
- baricitinib
- upadacitinib
- abrocitinib
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Li, X., Hu, Q., & Xu, T. (2025). Janus kinase inhibitors and the risk of infections: a network meta-analysis across disease indications. Expert Opinion on Drug Safety, 1–13. https://doi.org/10.1080/14740338.2025.2502037
How many times has this paper been cited?
10 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Xiaoqi Li, Qiaozhi Hu, Ting Xu.
What is the DOI of this paper?
10.1080/14740338.2025.2502037, permanently at https://doi.org/10.1080/14740338.2025.2502037. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.